Emmvee Photovol. Q2 FY27 Earnings Call — Analysis (NSE: EMMVEE)
Emmvee reported strong Q2FY27 revenue growth of 39% YoY to ₹1,576 Cr with 35.3% EBITDA margin, on track to commission its 6 GW cell/module expansion by Q4FY27.
Result quality: stable — Steady quarter. Management sentiment: optimistic.
The take
Q2FY27 Revenue from Operations ₹1,576 Cr ( +39% YoY ) . Guidance raised — Q4FY27 remaining fy27 cell capacity ut… close to 90% . New story: Integrated capacity expansion execution .
Results
Revenue grew 39% YoY to ₹1,576 Cr, EBITDA increased 39% to ₹557 Cr (35.3% margin), and PAT surged 61% to ₹382 Cr supported by reduced finance costs.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from Operations | ₹1,576 Cr | +39% | yoy · Q2FY27 |
| EBITDA | ₹557 Cr | +39% | yoy · Q2FY27 |
| EBITDA Margin | 35.3% | +flat | yoy · Q2FY27 |
| Profit After Tax | ₹382 Cr | +61% | yoy · Q2FY27 |
| PAT Margin | 24% | +300bps | yoy · Q2FY27 · vs 21% in Q2FY26 |
| Revenue from Operations | ₹3,132 Cr | +45% | yoy · H1FY27 |
| EBITDA | ₹1,105 Cr | +47% | yoy · H1FY27 |
| Profit After Tax | ₹762 Cr | +79% | yoy · H1FY27 |
| Operating Cash Flow | ₹410 Cr | +239% | yoy · H1FY27 · vs ₹121 Cr in H1FY26 |
| Finance Costs | ₹9.5 Cr | -82.8% | yoy · Q2FY27 · vs ₹55.2 Cr in Q2FY26 |
| Order Book | 10.4 GW | point_in_time · Q2FY27 · Sep-26 | |
| Order Inflow | 1.5 GW | none · Q2FY27 · inflow during quarter |
Guidance
Management reiterated full-year FY27 EBITDA guidance of ₹2,200–2,400 Cr, noting high confidence in reaching the upper end.
What management committed to
- Cell capacity utilization is expected to remain close to 90% for the remaining two quarters of FY27. — close to 90%, Q4FY27
- Module utilization will remain broadly in the range of 45% to 60% going forward. — 45% to 60%, FY27
- Approximately 5 to 5.5 GW of the current order book will be delivered within the next 12-15 months. — 5-5.5 GW, Q2FY28
- The remaining M10R cell capacity will be fully converted to G12R configuration. — FY27
- Interest on expansion debt will be capitalised until December 2026, partially recognised in Q4FY27, and fully expensed from Q1FY28. — partial in Q4FY27, full from Q1FY28, Q1FY28
Key themes
TOPCon expansion and margin resilience
How the narrative shifted
- ALMM List 2 DCR demand shift: The narrative shifted from anticipation of policy to explicit validation via order book composition.
- Integrated capacity expansion execution: The story moved from 'on track' to specific execution milestones being met or exceeded.
- Backward integration into ingot/wafer: The conditionality was deepened from 'subject to ALMM List 3' to a broader set of economic viability hurdles.
- Domestic cell supply tightness: No major reframing; the thesis is now supported by observable performance data rather than market commentary.
- Rising cell utilization and mix benefits: The narrative graduated from expected trends to a proven performance metric driving earnings quality.
- Geopolitical raw-material risk management: Not explicitly discussed in the current call, suggesting management has moved on from this narrative or considers the risk successfully managed.
- Product quality differentiation enabling margin defence: Management consistently frames its two-year head start in TOPCon, product reliability, and customer trust as the key structural reason it can maintain EBITDA spreads against competitive price pressure.
- Strategic cost efficiency management: Management details specific operational levers (silver reduction from 220mg to 60mg, renewable open-access power, AGV automation) as evidence of a proactive cost-culture that neutralises raw material inflation.
- G12R cell transition driving efficiency: Management positions the rapid transition to G12R cells (>50% converted) as a key source of product-level margin improvement and higher wattage for customers.
Operational commentary
- Commissioning timelines reaffirmed for 6 GW integrated project: module facility expected by December 2026 and TOPCon cell facility by March 2027.
- Total post-expansion capacity will reach ~16.3 GW of modules and ~8.9 GW of TOPCon cells, designed for balanced annual throughput.
- Solar cell production rose 61% YoY to 513 MW with 89% effective capacity utilization, while module production rose 40% YoY to 952 MW at 44% utilization.
- Transitioned more than 50% of cell capacity to G12R format, delivering ~9.5W per cell vs 8W earlier, with reduced silver paste consumption (60-65mg vs 220mg historically).
- Order book mix stands at ~70% DCR and ~30% non-DCR; 5.0-5.5 GW of the 10.4 GW total order book is scheduled for delivery within the next 12-15 months.
- Planning 9 GW backward integration into ingots and wafers in two phases (5 GW + 4 GW), conditional upon ALMM List-III enforcement and economic viability.
Analyst Q&A
Q. Why is the capex of ₹5,500 Cr for 6 GW cell and module (~₹9 Cr/GW) higher than current industry benchmarks of ₹5-6 Cr/GW?
Management clarified that hard cost is ₹4,600 Cr for both 6 GW cell and 6 GW module combined, while ~₹700-900 Cr covers IDC, contingency, and working capital margin money; capex also embeds high automation and silver-saving technologies.
Q. Can management provide the exact split of merchant cell sales vs internal consumption and the split of DCR order book between cells and modules?
Management noted merchant cell sales were marginally higher QoQ, but declined to provide the exact breakdown of cell vs module sales on the call, offering to share details offline.
Q. Will finance costs rise in Q3FY27 following ₹828 Cr debt drawdown for expansion?
Management explained that interest is capitalized until commercial operations begin (December for modules, March for cells); P&L finance cost will see partial recognition in Q4FY27 and full recognition from Q1FY28.
Q. Does management see risk of ALMM-II being deferred beyond December 2026?
Management considers deferment extremely unlikely given that sufficient realignment time was provided, open-access DCR transition is underway, and government focus is shifting to ALMM-III for ingots/wafers.
Research and educational content only. Not investment advice.